Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
To assess duration of action of the compound in suppressing the early and late allergen response in asthma patients
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and/or female subjects between the ages of 18 and 60 years, inclusive.
A history or diagnosis of asthma that requires the use of beta 2 agonist bronchodilators (eg Salbutamol).
Women who could become pregnant must use appropriate birth control throughout the study and pregnancy tests must be negative on entering the study and prior to dosing in the clinic.
You may not be if
Subjects who have been hospitalized for the treatment of asthma within three months prior to study entry, or have been hospitalized more than twice in last 12 months.
Subjects who have experienced a lower respiratory tract infection (eg bronchitis or pneumonia) or significant asthma instability in the 4 weeks prior to study entry.
